ScholarIQanswers from OpenAlex

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA

PaperCitations, authors & open-access status

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA have?

ScholarIQcitation count

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA has 62 citations in the OpenAlex counts ScholarIQ stores.

When was Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA published?

ScholarIQyear

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA has 2015 year in the ScholarIQ index.

What is the open-access status of Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA?

ScholarIQoa status

Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA has diamond oa status in the ScholarIQ index.

What is the DOI of Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA?

ScholarIQdoi

The DOI for Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA is on the source record.

What is the PMID of Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA?

ScholarIQpmid

The PMID for Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA is on the source record.

What is the OpenAlex record for Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA?

ScholarIQopenalex

The OpenAlex for Efficacy of CDK4 inhibition against sarcomas depends on their levels of CDK4 and p16ink4 mRNA is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial